News

The Manila Times8h
Amicus Therapeutics Announces First Quarter 2025 Financial Results and Corporate Updates
Amicus Therapeutics (Nasdaq: FOLD), a patient-dedicated global biotechnology company focused on developing and ...
The Manila Times23h
Rush Enterprises, Inc. Reports First Quarter 2025 Results, Announces $0.18 per Share Dividend
In the first quarter of 2025, the Company's gross revenues totaled $1.85 billion, a 1.1% decrease from $1.87 billion in the ...